AMGEN INC

NASDAQ: AMGN (Amgen Inc.)

Last update: 32 minutes ago

320.56

-3.80 (-1.17%)

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - General (US) Bullish Mixed
Drug Manufacturers - General (Global) Bullish Mixed
Stock Amgen Inc. Bearish Bullish

Stockmoo Score

-1.9

Similar Stocks

Stock Market Cap DY P/E P/B
AMGN 172 B 2.77% 55.27 29.05
GILD 94 B 4.07% 91.62 5.38
AZN 272 B 1.70% 42.53 6.52
SNY 131 B 7.78% 28.79 1.94
GRFS 6 B - 29.50 0.980
BIIB 29 B - 25.45 1.85

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Sector Healthcare
Industry Drug Manufacturers - General
Investment Style Large Value

Ownership

Name Date Shares Held
Vanguard Group Inc 30 Jun 2024 51,873,366
Blackrock Inc. 30 Jun 2024 46,042,729
State Street Corp 30 Jun 2024 28,971,481
Primecap Management Co/Ca/ 30 Jun 2024 14,447,127
Morgan Stanley 30 Jun 2024 14,362,478
Geode Capital Management, Llc 30 Jun 2024 12,019,038
Charles Schwab Investment Management Inc 30 Jun 2024 10,280,753
Capital International Investors 30 Jun 2024 8,378,960
Wells Fargo & Company/Mn 30 Jun 2024 7,677,589
Bank Of America Corp /De/ 30 Jun 2024 6,036,762
Northern Trust Corp 30 Jun 2024 5,852,782
Norges Bank 30 Jun 2024 5,807,622
Bank Of New York Mellon Corp 30 Jun 2024 5,363,611
Goldman Sachs Group Inc 30 Jun 2024 5,181,630
Royal Bank Of Canada 30 Jun 2024 5,087,364
52 Weeks Range
249.70 (-22%) — 346.85 (8%)
Price Target Range
303.00 (-5%) — 340.00 (6%)
High 340.00 (Argus Research, 6.06%) Buy
Median 332.00 (3.57%)
Low 303.00 (Morgan Stanley, -5.48%) Hold
Average 325.00 (1.39%)
Total 2 Buy, 1 Hold
Avg. Price @ Call 312.47
Firm Date Target Price Call Price @ Call
Morgan Stanley 11 Jul 2024 303.00 (-5.48%) Hold 325.09
Argus Research 27 Jun 2024 340.00 (6.06%) Buy 313.69
RBC Capital 14 Jun 2024 332.00 (3.57%) Buy 298.62

No data within this time range.

TTM Dividend Yield 2.77%
5Y Average Dividend Yield 2.85%
Expected Next Dividend Payment Mar 2025
Ex Date Announcement Date Payment Date Details
16 Aug 2024 02 Aug 2024 06 Sep 2024 2.25 Cash
16 May 2024 06 Mar 2024 07 Jun 2024 2.25 Cash
15 Feb 2024 12 Dec 2023 07 Mar 2024 2.25 Cash
16 Nov 2023 24 Oct 2023 08 Dec 2023 2.13 Cash
17 Aug 2023 01 Aug 2023 08 Sep 2023 2.13 Cash
17 May 2023 07 Mar 2023 08 Jun 2023 2.13 Cash
14 Feb 2023 12 Dec 2022 08 Mar 2023 2.13 Cash
16 Nov 2022 28 Oct 2022 08 Dec 2022 1.94 Cash
17 Aug 2022 03 Aug 2022 08 Sep 2022 1.94 Cash
16 May 2022 02 Mar 2022 08 Jun 2022 1.94 Cash
14 Feb 2022 03 Dec 2021 08 Mar 2022 1.94 Cash
15 Nov 2021 21 Oct 2021 08 Dec 2021 1.76 Cash
16 Aug 2021 30 Jul 2021 08 Sep 2021 1.76 Cash
14 May 2021 03 Mar 2021 08 Jun 2021 1.76 Cash
11 Feb 2021 16 Dec 2020 08 Mar 2021 1.76 Cash
13 Nov 2020 21 Oct 2020 08 Dec 2020 1.6 Cash
14 Aug 2020 23 Jul 2020 08 Sep 2020 1.6 Cash
15 May 2020 04 Mar 2020 08 Jun 2020 1.6 Cash
13 Feb 2020 11 Dec 2019 06 Mar 2020 1.6 Cash
14 Nov 2019 22 Oct 2019 06 Dec 2019 1.45 Cash
14 Aug 2019 02 Aug 2019 06 Sep 2019 1.45 Cash
16 May 2019 07 Mar 2019 07 Jun 2019 1.45 Cash
14 Feb 2019 07 Dec 2018 08 Mar 2019 1.45 Cash
15 Nov 2018 23 Oct 2018 07 Dec 2018 1.32 Cash
16 Aug 2018 31 Jul 2018 07 Sep 2018 1.32 Cash
16 May 2018 07 Mar 2018 08 Jun 2018 1.32 Cash
14 Feb 2018 12 Dec 2017 08 Mar 2018 1.32 Cash
16 Nov 2017 24 Oct 2017 08 Dec 2017 1.15 Cash
15 Aug 2017 28 Jul 2017 08 Sep 2017 1.15 Cash
15 May 2017 07 Mar 2017 08 Jun 2017 1.15 Cash
13 Feb 2017 20 Dec 2016 08 Mar 2017 1.15 Cash
14 Nov 2016 14 Oct 2016 08 Dec 2016 1 Cash
15 Aug 2016 22 Jul 2016 08 Sep 2016 1 Cash
13 May 2016 02 Mar 2016 08 Jun 2016 1 Cash
11 Feb 2016 15 Dec 2015 08 Mar 2016 1 Cash
12 Nov 2015 14 Oct 2015 07 Dec 2015 0.79 Cash
13 Aug 2015 28 Jul 2015 08 Sep 2015 0.79 Cash
12 May 2015 04 Mar 2015 05 Jun 2015 0.79 Cash
10 Feb 2015 17 Dec 2014 06 Mar 2015 0.79 Cash
10 Nov 2014 17 Oct 2014 05 Dec 2014 0.61 Cash
12 Aug 2014 25 Jul 2014 05 Sep 2014 0.61 Cash
13 May 2014 05 Mar 2014 06 Jun 2014 0.61 Cash
11 Feb 2014 13 Dec 2013 07 Mar 2014 0.61 Cash
12 Nov 2013 16 Oct 2013 06 Dec 2013 0.47 Cash
14 Aug 2013 26 Jul 2013 06 Sep 2013 0.47 Cash
14 May 2013 06 Mar 2013 07 Jun 2013 0.47 Cash
11 Feb 2013 13 Dec 2012 07 Mar 2013 0.47 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2024 6.75 3 2.11
2023 8.52 4 2.96
2022 7.76 4 2.96
2021 7.04 4 3.13
2020 6.40 4 2.78
2019 5.80 4 2.41
2018 5.28 4 2.71
2017 4.60 4 2.65
2016 4.00 4 2.74
2015 3.16 4 1.95
2014 2.44 4 1.53
2013 1.88 4 1.65
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria